GlassScriptPhysician profile
Vivek Sharma
NPI 1225297922
$1,116.24
in general payments reported to CMS, 2019-2025
15 companies · $164 in 2025
The $164 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $33.36 · 2021: $104 · 2022: $54.19 · 2023: $23.58 · 2024: $565 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $752.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $178.86 | 2022-2024 | Farxiga |
| Cormedix INC. | $156.36 | 2024 | Defencath |
| Ardelyx, INC. | $109.99 | 2024 | Xphozah 30 Mg |
| Aurinia Pharma U.S., INC. | $104.10 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $101.23 | 2024 | Jardiance |
| Alexion Pharmaceuticals, INC. | $100.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $93.38 | 2025 | |
| Fresenius USA Marketing, INC. | $65.71 | 2024-2025 | Velphoro, Velphoro |
| Calliditas Therapeutics US INC. | $57.29 | 2024 | |
| Veloxis Pharmaceuticals, INC. | $54.39 | 2019 | |
| Renalytix Ai, INC. | $23.58 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Scpharmaceuticals INC. | $20.40 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $18.56 | 2020 | |
| Nxstage Medical, INC. | $17.59 | 2019 | |
| Opko Pharmaceuticals, LLC | $14.80 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vivek Sharma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.